Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug-Reference-Cited by-同舟云学术

Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug

Published:2006-11 Issue:2 Volume:116 Page:150-158
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Ahmed Fariyal,Pakunlu Refika I.,Brannan Aaron,Bates Frank,Minko Tamara,Discher Dennis E.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference35 articles.

1. Weekly paclitaxel combined with pegylated liposomal doxorubicin (Caelyx™) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors

2. Pharmacokinetics of combined doxorubicin and paclitaxel in mice

3. Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel

4. Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

5. Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

Cited by 511 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths;Coordination Chemistry Reviews;2024-11

2. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

3. Artificial intelligence in nanotechnology for treatment of diseases;Journal of Drug Targeting;2024-08-27

4. Advanced Application of Polymer Nanocarriers in Delivery of Active Ingredients from Traditional Chinese Medicines;Molecules;2024-07-26

5. Polymeric nanotheranostics for solid tumor management: Recent developments and global regulatory landscape;Polymers for Advanced Technologies;2024-06